NCT02447458View on ClinicalTrials.gov

MLN3126 Single Rising Dose Study

PHASE1TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

MLN3126

MLN3126 tablets

DRUG

MLN3126 Placebo

MLN3126 placebo-matching tablets

Trial Locations (1)

Unknown

Eatontown

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY